insider trading  cooper ronald harold wilfred  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  cooper ronald harold wilfred select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  pm nana albireo pharma inc albo cooper ronald harold wilfredpresident and ceodirector   direct view option award  pm na albireo pharma inc albo cooper ronald harold wilfredpresident and ceodirector   direct view option award  pm na albireo pharma inc albo cooper ronald harold wilfredpresident and ceodirector   direct view option award  pm  genocea biosciences inc gnca cooper ronald harold wilfreddirector   direct view   secformcom all rights reserved archives        fri  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  ron cooper  albireo pharma inc  zoominfocom microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft   ronald harold wilfred cooper  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors ronald harold wilfred cooper check out list of companies and businesses related to ronald harold wilfred cooper find out ronald harold wilfred cooper address and contact details view other people related to ronald harold wilfred cooper  coworkers colleagues companions etc address co genocea biosciences inc  acorn park drive th floor cambridge  ma companies related to ronald harold wilfred cooper cikcompany namepositioncompany addressalbireo pharma incpresident and ceo  post office square suite  south boston genocea biosciences incdirector  acorn park drive cambridge  ronald harold wilfred cooper on the web persons related to ronald harold wilfred cooper  albireo pharma incnamepositioncitykrasner alandanburyab astrazenecasodertaljeplc astrazenecalondonginsberg barrydanburypaul s baviergeneral counsel danburypaul s baviergeneral counsel danburypaul s baviergeneral counselcorp sec danburypaul s baviergeneral counsel danburypaul s baviergeneral counselcorp sec danburydavid bondermanpereira briandanburyjulia r browndirector san diegojulia r browndirector danburymartha j carterchief regulatory officer morristowndonald m jr caseydirector danburyalbert chadirector danburyalbert chadirector danburydavid chiswelldirector bostonronald harold wilfred cooperpresident and ceo cambridgejames g coulterforth worthlorber danieldanburyscoon daveydanburyerrol b desouzaceo errol b desouzaceo danburyerrol b desouzaceo danburyerrol b desouzaceo danburyerrol b desouzaceo danburyerrol b desouzaceo and president danburyerrol b desouzaceo danburysteiner erikdanburyde souza erroldanburyrobert feldsteinvice president danburyrobert feldsteinvice president patents ip danburygary g gemignanichief financial officer danburymichel gerarddanburybarry h ginsbergdirector danburybarry h ginsbergdirector danburygreat point partners i lp owner greenwichgreat point partners i lp owner greenwichgreat point partners i lp owner greenwichgreat point partners i lp owner greenwichgreat point partners i lp owner greenwichgreat point partners llcgreenwichmichael gutchdirector bostonlieberman iradanburysamuel d isalynew yorkbrown juliedanburyalan seth krasnerchief medical officer danburyalan seth krasnerchief medical officer danburyalan seth krasnerchief medical officer danburyalan seth krasnerchief medical officer danburydavid kroindirector danburydavid kroindirector danburydavid kroindirector danburyira liebermandirector danburyira liebermandirector danburyira liebermandirector danburydaniel lorberdirector danburydaniel lorberdirector danburyjan mattssonchief operating officer bostonalastair mckinnonedinburghgerard j michelcfo vp of corp and devtreas danburygerard j michelcfo vp of corp dev and treas danburygerard j michelcfo vp of corp and devtreas danburyarlene morrisdirector san diegoorbimed advisors llc owner new yorkorbimed advisors llcdirector new yorkbavier pauldanburybrian jg pereiradirector danburybrian jg pereiradirector danburybrian jg pereiradirector danburyandreas pfutznerchief medical officer danburyandreas pfutznerchief medical officer in europ danburyphase partners ltdedinburghphase ventures iii general partner ltdedinburghphase ventures iii gp lpedinburghphase ventures iii lpedinburghroderike pohldanburyroderike pohlvp research danburyroderike pohlvp research danburyroderike pohlvice president research danburydenise pollardknightdirector cambridgeheather prestondirector fort worthf scott redingchief financial officer danburycharles a sandersdirector danburycharles a sandersdirector danburycharles a sandersdirector danburycharles a sanderschapel hilldavey scoondirector bedforddavey scoondirector danburypaul j sekhridanburycharles sermonedinburghthomas a sheacfo and treasurer bostonparesh sonichief medical officer mysticerik steinervice president operations danburyerik steinervicepresident operations danburyerik steinervicepresident operations danburyerik steinervicepresident operations danburysolomon steinerpresident  ceo danburysolomon steinerdirector danburysolomon steinerdirector danburysteiner ventures llcmt kiscosteiner ventures llc owner danburytpg group holdings sbs advisors incfort worthj arthur urciuolidirector danburyj arthur urciuolidirector danburyvivo ventures v llc owner palo altor timmis warecorp secy and general counsel danburyr timmis warecorp secy and general counsel danburyscott weismandirector danburyscott weismandirector danburysamuel p wertheimerdirector new yorksamuel p wertheimerdirector danburysamuel p wertheimerdirector danburypeter a zornchief corp officer gc  sec winstonsalempersons related to ronald harold wilfred cooper  genocea biosciences incnamepositioncityxavier asishcambridgekenneth batedirector cambridgekenneth batedirector cambridgekevin bittermandirector walthamkatrine bosleydirector cambridgewilliam d clarkpresident and ceo rockvillewilliam d clarkpresident and ceo cambridgewilliam d clarkpresident and ceo cambridgeronald harold wilfred cooperdirector cambridgeeinhorn daltoncambridgerobert e farrell jrvp of finance  administration cambridgejessica baker flechtnerchief scientific officer cambridgejessica baker flechtnersr vp of research cambridgesiber georgecambridgesiber georgecambridgesimeon georgedirector conshohockenpaul giannascavp of development cambridgepaul giannascavp of development cambridgeplc glaxosmithkline brentford middlesexseth v hetheringtonchief medical officer alpharettaseth v hetheringtoncambridgeseth v hetheringtonchief medical officer cambridgemichael j higginsdirector cambridgeeric s hoffmanchief business officer cambridgestephen j hoffmandirector carlislestephen j hoffmandirector walthamflechtner jessicacambridgeflechtner jessicacambridgejohnson  johnson owner new brunswickjohnson  johnson development corp et alnew brunswickbosley katrinecambridgebitterman kevincambridgebitterman kevincambridgechen leoncambridgelux capital management llc new yorklux venture associates ii llcnew yorklux venture partners ii lpnew yorklux ventures ii lpnew yorklux ventures ii sidecar ii llcnew yorklux ventures ii sidecar lpnew yorkhoward mayerdirector cambridgegiannasca paulcambridgegiannasca paulcambridgepolaris venture management co v llc owner walthampolaris venture management co v llc owner walthampolaris venture management co v llc owner walthampolaris venture partners entrepreneurs fund v lpwalthampolaris venture partners entrepreneurs fund v lpwalthampolaris venture partners entrepreneurs fund v lpwalthampolaris venture partners founders fund v lpwalthampolaris venture partners founders fund v lpwalthampolaris venture partners founders fund v lpwalthampolaris venture partners special founders fund v lpwalthampolaris venture partners special founders fund v lpwalthampolaris venture partners special founders fund v lpwalthampolaris venture partners v lpwalthampolaris venture partners v lpwalthampolaris venture partners v lpwalthamjonathan poolechief financial officer cambridgevenkataramani ravicambridgefarrell jr robertcambridgefarrell jr robertcambridgepaull robertcambridgepaull robertcambridgehetherington sethcambridgegeorge siberdirector new yorkgeorge simeoncambridgegeorge simeoncambridgehoffman stephencambridgehoffman stevecambridgeravichandran venkataramanicambridgeclark williamcambridgeclark williamcambridge genocea biosciences inc via public  cooper ronald harold wilfred hello   united states  news international news education environment healthcare technology internet science social and nonprofit local news politicsand policy government politics local government international policy businessand economy economy finance stock markets jobs and labor company news industry news aerospace agriculture chemicals commodities construction consumer electronics defense energy nuclear energy oil and gas renewable energy financial services banking insurance fishing and aquaculture manufacturing information technology metals and mining pharmaceuticals and biotechnology real estate professional and business services legal telecommunications tobacco retail transportation air transportation maritime transportation rail transportation road transportation utilities forestry and wood industry artsand culture art books and literature entertainment cinema media radio and television music lifestyleand leisure automotive home and garden fashion and luxury clothing and textile food travel and hospitality boating and yachting sports baseball basketball boxing cricket cycling football american football australian football soccer golf hockey racing rugby sailing skiing and winter sports tennis volleyball noodls browser compatibility check the security settings of your browser are blocking the execution of scripts to use noodls javascript support must be enabled please change your browsers security settings to enable javascript if you have changed your browsers security settings you can click here related announcements company news commscope holding company inc we need to stop thinking “not in my backyard” arcbest corporation arcbest announces second quarter  results drilquip inc drilquip inc announces results for second quarter  more financial services sabra health care reit inc sabra health care reit files investor presentation mednax inc mednax reports second quarter gaap eps of  nasdaq inc redfin nasdaq rdfn to ring the nasdaq stock market opening bell in more search genocea biosciences inc   press release  distributed by public on   cooper ronald harold wilfred form  omb approval omb number  estimated average burden hours per response   name and address of reporting person cooper ronald harold wilfred  date of event requiring statement mmddyyyy  issuer name and ticker or trading symbol genocea biosciences inc gnca co genocea biosciences inc  acorn park drive th floor  relationship of reporting persons to issuer check all applicable  x  director   owner  officer give title below  other specify below cambridge ma   if amendment date original filed mmddyyyy  individual or jointgroup filing check applicable line  x  form filed by one reporting person  form filed by more than one reporting person title of security instr   amount of securities beneficially owned instr   ownership form direct d or indirect i instr   nature of indirect beneficial ownership instr   title of derivate security instr   date exercisable and expiration date mmddyyyy  title and amount of securities underlying derivative security instr   conversion or exercise price of derivative security  ownership form of derivative security direct d or indirect i instr   nature of indirect beneficial ownership instr  date exercisable expiration date title amount or number of shares explanation of responses remarks exhibit list  exhibit  power of attorney no securities are beneficially owned reporting owners reporting owner name  address director  owner officer other cooper ronald harold wilfred co genocea biosciences inc  acorn park drive th floor cambridge ma  x signatures s jonathan poole attorneyinfact  signature of reporting person date reminder report on a separate line for each class of securities beneficially owned directly or indirectly  if the form is filed by more than one reporting person see instruction bv  intentional misstatements or omissions of facts constitute federal criminal violations see  usc  and  usc ffa note file three copies of this form one of which must be manually signed if space is insufficient see instruction  for procedure persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid omb control number sharing and personal tools please select the service you want to use newsvine digg delicious stumbleupon technorati buzz favorites google reader public link please use the above public link if you want to share this noodl on another website close smartlinks  genocea biosciences inc  company news  business announcements  financial services  research firms and institutes  nasdaq  börse frankfurt  börse berlin  back  view original format copyright  public technologies inc  privacy policy  terms of use  contact genocea biosciences inc via public  cooper ronald harold wilfred hello   united states  news international news education environment healthcare technology internet science social and nonprofit local news politicsand policy government politics local government international policy businessand economy economy finance stock markets jobs and labor company news industry news aerospace agriculture chemicals commodities construction consumer electronics defense energy nuclear energy oil and gas renewable energy financial services banking insurance fishing and aquaculture manufacturing information technology metals and mining pharmaceuticals and biotechnology real estate professional and business services legal telecommunications tobacco retail transportation air transportation maritime transportation rail transportation road transportation utilities forestry and wood industry artsand culture art books and literature entertainment cinema media radio and television music lifestyleand leisure automotive home and garden fashion and luxury clothing and textile food travel and hospitality boating and yachting sports baseball basketball boxing cricket cycling football american football australian football soccer golf hockey racing rugby sailing skiing and winter sports tennis volleyball noodls browser compatibility check the security settings of your browser are blocking the execution of scripts to use noodls javascript support must be enabled please change your browsers security settings to enable javascript if you have changed your browsers security settings you can click here related announcements finance commscope holding company inc we need to stop thinking “not in my backyard” arcbest corporation arcbest announces second quarter  results drilquip inc drilquip inc announces results for second quarter  more company news sabra health care reit inc sabra health care reit files investor presentation tenneco inc tenneco reports second quarter  results ascent solar technologies inc ascent solar demonstrates breadth of capabilities at the us special more search genocea biosciences inc   press release  distributed by public on   cooper ronald harold wilfred form    check this box if no longer subject to section  form  or form  obligations may continue see instruction b united states securities and exchange commission washington dc  omb approval omb number  estimated average burden hours per response   name and address of reporting person cooper ronald harold wilfred  issuer name and ticker or trading symbol genocea biosciences inc  gnca   relationship of reporting persons to issuer check all applicable  x  director   owner  officer give title below  other specify below co genocea biosciences inc  acorn park drive th floor  date of earliest transaction mmddyyyy cambridge ma   if amendment date original filed mmddyyyy  individual or jointgroup filing check applicable line  x  form filed by one reporting person  form filed by more than one reporting person title of security instr   trans date a deemed execution date if any  trans code instr   securities acquired a or disposed of d instr   and   amount of securities beneficially owned following reported transactions instr  and   ownership form direct d or indirect i instr   nature of indirect beneficial ownership instr  code v amount a or d price  title of derivate security instr   conversion or exercise price of derivative security  trans date a deemed execution date if any  trans code instr   number of derivative securities acquired a or disposed of d instr   and   date exercisable and expiration date  title and amount of securities underlying derivative security instr  and   price of derivative security instr   number of derivative securities beneficially owned following reported transactions instr   ownership form of derivative security direct d or indirect i instr   nature of indirect beneficial ownership instr  code v a d date exercisable expiration date title amount or number of shares stock option right to buy   a    common stock    d explanation of responses   the option vests annually in equal installments over a threeyear period beginning on the date of grant reporting owners reporting owner name  address director  owner officer other cooper ronald harold wilfred co genocea biosciences inc  acorn park drive th floor cambridge ma  x signatures s jonathan poole attorneyinfact  signature of reporting person date reminder report on a separate line for each class of securities beneficially owned directly or indirectly  if the form is filed by more than one reporting person see instruction bv  intentional misstatements or omissions of facts constitute federal criminal violations see  usc  and  usc ffa note file three copies of this form one of which must be manually signed if space is insufficient see instruction  for procedure persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid omb control number sharing and personal tools please select the service you want to use newsvine digg delicious stumbleupon technorati buzz favorites google reader public link please use the above public link if you want to share this noodl on another website close smartlinks  genocea biosciences inc  finance  derivative securities  company news  directors dealing and insider transactions  financial services  research firms and institutes  nasdaq  börse frankfurt  börse berlin  back  view original format copyright  public technologies inc  privacy policy  terms of use  contact genocea biosciences  cooper ronald harold wilfred  traders log in email password remember forgot password  become a member for free sign up sign up new membersign up for free new customerdiscover our portfolios united states united kingdom france deutschland schweiz de suisse fr settings dynamic quotes  offon markets equities north americaeuropeasiaoceaniamiddle east» more equities indexes dow jonessp nasdaq tsx compftse » more indexes currency  forex eur  usdgbp  usdusd  jpyusd  cadaud  usd» more currencies commodities goldcrude oil wticrude oil brentsilverplatinum» more commodities news latest news companiesmarketseconomycurrency  forexcommoditiesinterest ratesbusiness leadersfinancial calendareconomic calendar listed company analyst recorumorsiposcapital markets transactionsnew contractsprofits warningsappointmentspress releaseseventscorporate actions sector news energybasic materialsindustrialsconsumer cyclicalconsumer noncyclicalfinancialshealthcaretechnologytelecommunications servicesutilities analysis all analysiscommentariesindex analysisstock trading strategiescommodity analysisforex analysis stock picks all stock picks portfolios my portfolio virtual portfolios traders portfolios european portfoliousa portfolioasian portfolio screeners market screener homefundamental analyse top investor ratingtop trading ratingtop consensusgrowth stocksyield stockslow valuations technical analysis oversold stocksoverbought stocksclose to resistancesclose to supportsaccumulation phasemost volatile stocks watchlists my watchlists watchlists top lists yield stocksgrowth stocksundervalued stocks top  flop top news most read newshot news top fundamentals top capitalizationtop yieldtop pertop consensustop fundamentals top technicals top rsiunusual volumestop gapstop stim top movers top usatop canadatop uktop germanytop europetop asia tools market screenerdynamic chartfinancial calendareconomic calendarsector researchcurrency converter our services premium accessdiscover our services traders homepage    equities    nasdaq    genocea biosciences inc    gnca genocea biosciences inc gnca add to my list    mes dernières consultmost popular manage my lists  delayed     pm  usd     genocea bioscie  reports positive topline month phase b data f  insider trading  gnca – cfo sold  shares of stock  genocea bioscie  current report summaryquoteschartsnewsanalysiscalendarcompanyfinancialsconsensusrevisions news summarymost relevantall newssector newstweets genocea biosciences  cooper ronald harold wilfred    pm cest send by mail  last name  name  from  to  you can enter multiple email addresses separated by commas message  required fields form    check this box if no longer subject to section  form  or form  obligations may continue see instruction b united states securities and exchange commission washington dc  omb approval omb number  estimated average burden hours per response   name and address of reporting person cooper ronald harold wilfred  issuer name and ticker or trading symbol genocea biosciences inc  gnca   relationship of reporting persons to issuer check all applicable  x  director   owner  officer give title below  other specify below co genocea biosciences inc  acorn park drive th floor  date of earliest transaction mmddyyyy cambridge ma   if amendment date original filed mmddyyyy  individual or jointgroup filing check applicable line  x  form filed by one reporting person  form filed by more than one reporting person title of security instr   trans date a deemed execution date if any  trans code instr   securities acquired a or disposed of d instr   and   amount of securities beneficially owned following reported transactions instr  and   ownership form direct d or indirect i instr   nature of indirect beneficial ownership instr  code v amount a or d price  title of derivate security instr   conversion or exercise price of derivative security  trans date a deemed execution date if any  trans code instr   number of derivative securities acquired a or disposed of d instr   and   date exercisable and expiration date  title and amount of securities underlying derivative security instr  and   price of derivative security instr   number of derivative securities beneficially owned following reported transactions instr   ownership form of derivative security direct d or indirect i instr   nature of indirect beneficial ownership instr  code v a d date exercisable expiration date title amount or number of shares stock option right to buy   a    common stock    d explanation of responses   the option vests annually in equal installments over a threeyear period beginning on the date of grant reporting owners reporting owner name  address director  owner officer other cooper ronald harold wilfred co genocea biosciences inc  acorn park drive th floor cambridge ma  x signatures s jonathan poole attorneyinfact  signature of reporting person date reminder report on a separate line for each class of securities beneficially owned directly or indirectly  if the form is filed by more than one reporting person see instruction bv  intentional misstatements or omissions of facts constitute federal criminal violations see  usc  and  usc ffa note file three copies of this form one of which must be manually signed if space is insufficient see instruction  for procedure persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid omb control number genocea biosciences inc published this content on  june  and is solely responsible for the information contained herein distributed by public unedited and unaltered on  june   utc original documenthttpirgenoceacomsecfilingcfmfilingidcik public permalinkhttpwwwpublicnowcomviewdfcbefaae  latest news on genocea biosciences inc  genocea biosciences inc  todays research reports on trending tickers genocea   genocea biosciences  reports positive topline month phase b data for gen  insider trading activity genocea bio  gnca – cfo sold  shares of s  genocea biosciences  current report  genocea biosciences inc nasdaq  gnca files an k regulation fd disclosure  genocea biosciences  reports positive topline month phase b data for gen  genocea biosciences inc  regulation fd disclosure financial statements and e  genocea reports positive topline month phase b data for gen in geni  genocea added to russell ® and russell ® indices  genocea biosciences  current report more news news from seekingalpha  genocea biosciencess gnca conference call on positive gen phase b res  premarket gainers as of    am  biotech forum daily digest  dynavax technologies moment of truth arrives  premarket gainers as of    am  genocea reports positive topline month phase b data for gen in genit financials  sales   m ebit   m net income   m finance   m yield   pe ratio   pe ratio  ev  sales  x ev  sales  x capitalization  m more financials chart genocea biosciences inc duration  auto  months  months  months  months  year  years  years  years max period  day week fullscreen chart technical analysis trends genocea biosciences inc short termmidtermlong termtrendsbullishneutralbullish technical analysis income statement evolution please enable javascript in your browsers settings to use dynamic charts more financials consensus sell buy mean consensus outperform number of analysts  average target price   spread  average target  consensus details eps revisions please enable javascript in your browsers settings to use dynamic charts more estimates revisions managers nametitlewilliam d clark president chief executive officer  director katrine s bosley chairman jonathan michael poole chief financial officer  headinvestor relations jessica baker flechtner chief scientific officer seth v hetherington chief medical officer more about the company sector and competitors st jancapitalization m genocea biosciences inc incyte corporation  quintiles ims holdings inc  lonza group  celltrion inc  alkermes plc  more results traderscom marketsnewsanalysisstock picksportfoliosscreenerswatchliststop  floptoolsour servicesabout surperformance sascontact usadvertiselegal informationsabout usstay connected facebooktwitterpartners börse aktien kurse und nachrichtenbest tweets copyright   surperformance all rights reserved slave genocea biosciences  cooper ronald harold wilfred  traders log in email password remember forgot password  become a member for free sign up sign up new membersign up for free new customerdiscover our portfolios united states united kingdom france deutschland schweiz de suisse fr settings dynamic quotes  offon markets equities north americaeuropeasiaoceaniamiddle east» more equities indexes dow jonessp nasdaq tsx compftse » more indexes currency  forex eur  usdgbp  usdusd  jpyusd  cadaud  usd» more currencies commodities goldcrude oil wticrude oil brentsilverplatinum» more commodities news latest news companiesmarketseconomycurrency  forexcommoditiesinterest ratesbusiness leadersfinancial calendareconomic calendar listed company analyst recorumorsiposcapital markets transactionsnew contractsprofits warningsappointmentspress releaseseventscorporate actions sector news energybasic materialsindustrialsconsumer cyclicalconsumer noncyclicalfinancialshealthcaretechnologytelecommunications servicesutilities analysis all analysiscommentariesindex analysisstock trading strategiescommodity analysisforex analysis stock picks all stock picks portfolios my portfolio virtual portfolios traders portfolios european portfoliousa portfolioasian portfolio screeners market screener homefundamental analyse top investor ratingtop trading ratingtop consensusgrowth stocksyield stockslow valuations technical analysis oversold stocksoverbought stocksclose to resistancesclose to supportsaccumulation phasemost volatile stocks watchlists my watchlists watchlists top lists yield stocksgrowth stocksundervalued stocks top  flop top news most read newshot news top fundamentals top capitalizationtop yieldtop pertop consensustop fundamentals top technicals top rsiunusual volumestop gapstop stim top movers top usatop canadatop uktop germanytop europetop asia tools market screenerdynamic chartfinancial calendareconomic calendarsector researchcurrency converter our services premium accessdiscover our services traders homepage    equities    nasdaq    genocea biosciences inc    gnca genocea biosciences inc gnca add to my list    mes dernières consultmost popular manage my lists  delayed     pm  usd     genocea bioscie  reports positive topline month phase b data f  insider trading  gnca – cfo sold  shares of stock  genocea bioscie  current report summaryquoteschartsnewsanalysiscalendarcompanyfinancialsconsensusrevisions news summarymost relevantall newssector newstweets genocea biosciences  cooper ronald harold wilfred    pm cest send by mail  last name  name  from  to  you can enter multiple email addresses separated by commas message  required fields form  omb approval omb number  estimated average burden hours per response   name and address of reporting person cooper ronald harold wilfred  date of event requiring statement mmddyyyy  issuer name and ticker or trading symbol genocea biosciences inc gnca co genocea biosciences inc  acorn park drive th floor  relationship of reporting persons to issuer check all applicable  x  director   owner  officer give title below  other specify below cambridge ma   if amendment date original filed mmddyyyy  individual or jointgroup filing check applicable line  x  form filed by one reporting person  form filed by more than one reporting person title of security instr   amount of securities beneficially owned instr   ownership form direct d or indirect i instr   nature of indirect beneficial ownership instr   title of derivate security instr   date exercisable and expiration datemmddyyyy  title and amount of securities underlying derivative security instr   conversion or exercise price of derivative security  ownership form of derivative security direct d or indirect i instr   nature of indirect beneficial ownership instr  date exercisable expiration date title amount or number of shares explanation of responses remarks exhibit list  exhibit  power of attorney no securities are beneficially owned reporting owners reporting owner name  address director  owner officer other cooper ronald harold wilfred co genocea biosciences inc  acorn park drive th floor cambridge ma  x signatures s jonathan poole attorneyinfact  signature of reporting person date reminder report on a separate line for each class of securities beneficially owned directly or indirectly  if the form is filed by more than one reporting person see instruction bv  intentional misstatements or omissions of facts constitute federal criminal violations see  usc  and  usc ffa note file three copies of this form one of which must be manually signed if space is insufficient see instruction  for procedure persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid omb control number genocea biosciences inc published this content on  june  and is solely responsible for the information contained herein distributed by public unedited and unaltered on  june   utc original documenthttpirgenoceacomsecfilingcfmfilingidcik public permalinkhttpwwwpublicnowcomviewbcbdfdcedaacaaece  latest news on genocea biosciences inc  genocea biosciences inc  todays research reports on trending tickers genocea   genocea biosciences  reports positive topline month phase b data for gen  insider trading activity genocea bio  gnca – cfo sold  shares of s  genocea biosciences  current report  genocea biosciences inc nasdaq  gnca files an k regulation fd disclosure  genocea biosciences  reports positive topline month phase b data for gen  genocea biosciences inc  regulation fd disclosure financial statements and e  genocea reports positive topline month phase b data for gen in geni  genocea added to russell ® and russell ® indices  genocea biosciences  current report more news news from seekingalpha  genocea biosciencess gnca conference call on positive gen phase b res  premarket gainers as of    am  biotech forum daily digest  dynavax technologies moment of truth arrives  premarket gainers as of    am  genocea reports positive topline month phase b data for gen in genit financials  sales   m ebit   m net income   m finance   m yield   pe ratio   pe ratio  ev  sales  x ev  sales  x capitalization  m more financials chart genocea biosciences inc duration  auto  months  months  months  months  year  years  years  years max period  day week fullscreen chart technical analysis trends genocea biosciences inc short termmidtermlong termtrendsbullishneutralbullish technical analysis income statement evolution please enable javascript in your browsers settings to use dynamic charts more financials consensus sell buy mean consensus outperform number of analysts  average target price   spread  average target  consensus details eps revisions please enable javascript in your browsers settings to use dynamic charts more estimates revisions managers nametitlewilliam d clark president chief executive officer  director katrine s bosley chairman jonathan michael poole chief financial officer  headinvestor relations jessica baker flechtner chief scientific officer seth v hetherington chief medical officer more about the company sector and competitors st jancapitalization m genocea biosciences inc incyte corporation  quintiles ims holdings inc  lonza group  celltrion inc  alkermes plc  more results traderscom marketsnewsanalysisstock picksportfoliosscreenerswatchliststop  floptoolsour servicesabout surperformance sascontact usadvertiselegal informationsabout usstay connected facebooktwitterpartners börse aktien kurse und nachrichtenbest tweets copyright   surperformance all rights reserved slave cooper ronald harold wilfred  genocea biosciences insider transactions  tipranks go prologin  sign up follow✓get real time transactionsinsider detailscooper ronald harold wilfredgenocea biosciences gncadirector not rankedcooper ronald harold wilfreds performancecooper ronald harold wilfred has not reported any informative transactions and therefore cannot be rankedhow are insiders ranked cooper ronald harold wilfreds trading historybased on form  follow✓get real time transactionscompany nameinsider positionholding valuelast transactionlast transaction amountlast transaction dategncagenocea biosciencesdirectordelbiodbiodel incsee all insider trading from today you may also likemeet our smart portfolio see what top analysts say about your stocksget a breakdown of the different strategies based on detected insider trading activityfind the best performing analyst in each sector follow them so you never miss a recommendationrelated linkshow can i benefit from insider trading see the top  corporate insiders go to hot stocks by insiders find which stocks insiders traded today become a tipranks memberget the best investing tips  hacks straight to your emailfree membershipsubmitinsider trading daily newsletterprofessional daytrading strategy based on predictive insider transactionsannual return learn more powered by